Evidence map›Paper›PMID 32474061›Full record

ArticleContraception2020

"Shared risk": Reframing risk analysis in the ethics of novel male contraceptives.

Georgina D Campelia, Carmen Abbe, Logan M Nickels, Evy McElmeel, John K Amory

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Contraception, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. The landscape of male contraception A narrative review.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2024
    Review
  6. Hormone Regulation in Testicular Development and Function.International journal of molecular sciences · 2024
    Review
  7. Hormonal Male Contraception: Getting to Market.Frontiers in endocrinology · 2022
    Article
  8. Update on Novel Hormonal and Nonhormonal Male Contraceptive Development.The Journal of clinical endocrinology and metabolism · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Georgina D CampeliaDepartment of Bioethics & Humanities, United States.
Carmen AbbeDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, United States.
Logan M NickelsMale Contraceptive Initiative, Durham, NC, United States.
Evy McElmeelPrivate Practice, Seattle, WA, United States.
John K AmoryDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, United States. Electronic address: jamory@uw.edu.

Funding

ALDH1A1/A2 Inhibitors for Male ContraceptionR01HD098039 · NICHD · UNIVERSITY OF WASHINGTON · PI AMORY, JOHN K. · 2019 to 2023
$1.9M
Retinoic Acid in Male InfertilityK24HD082231 · NICHD · UNIVERSITY OF WASHINGTON · PI AMORY, JOHN K. · 2015 to 2019
$638k
NICHD NIH HHS K24 HD082231NICHD NIH HHS R01 HD098039
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Contraceptive Agents, MaleContraceptionHumansMaleRisk AssessmentContraceptive Agents, MaleContraceptionMale contraceptionReproductive ethicsReproductive rightsSide effectsUnintended pregnancy

Identifiers

PMID32474061
PMCPMC8168714

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.